BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Guerreiro SG, Cruz-Martins N, Batiha GE. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus. Front Cardiovasc Med 2021;8:644095. [PMID: 34124187 DOI: 10.3389/fcvm.2021.644095] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Aseel Awad Alsaidan, Hayder M. Al‐Kuraishy, Ali I. Al‐Gareeb, Athanasios Alexiou, Marios Papadakis, Khalid Adel Alsayed, Hebatallah M. Saad, Gaber El‐Saber Batiha. The potential role of SARS‐CoV‐2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread. Immun Inflamm Dis 2023;11:e798. [ DOI: 10.1002/iid3.798] [Reference Citation Analysis]
2 Nesterova IV, Atazhakhova MG, Teterin YV, Matushkina VA, Chudilova GA, Mitropanova MN. THE ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS) IN THE IMMUNOPATHOGENESIS OF SEVERE COVID-19: POTENTIAL IMMUNOTHERAPEUTIC STRATEGIES REGULATING NET FORMATION AND ACTIVITY. Russian Journal of Infection and Immunity 2023. [DOI: 10.15789/2220-7619-tro-2058] [Reference Citation Analysis]
3 Roubinian NH, Vinson DR, Pai AP, Myers LC, Skarbinski J, Lee C, Mark DG, Liu VX. Risk of VTE in Nonrespiratory and Respiratory Presentations of COVID-19 in Critically Ill Patients. Chest 2023:S0012-3692(23)00188-5. [PMID: 36787875 DOI: 10.1016/j.chest.2023.02.008] [Reference Citation Analysis]
4 Kumwichar P, Chongsuvivatwong V. COVID-19 pneumonia and the subsequent risk of getting active pulmonary tuberculosis: a population-based dynamic cohort study using national insurance claims databases. EClinicalMedicine 2023;56:101825. [PMID: 36694864 DOI: 10.1016/j.eclinm.2023.101825] [Reference Citation Analysis]
5 Al-Kuraishy HM, Al-Gareeb AI, Hetta HF, Alexiou A, Papadakis M, Batiha GE. Heparanase is the possible link between monkeypox and Covid-19: robust candidature in the mystic and present perspective. AMB Express 2023;13:13. [PMID: 36705773 DOI: 10.1186/s13568-023-01517-y] [Reference Citation Analysis]
6 Gashimova NR, Bitsadze VO, Pankratyeva LL, Khizroeva JK, Slukhanchuk EV, Grigoreva KN, Tsibizova VI, Gris J, Elalamy I, Ay C, Blinov DV, Serov VN, Makatsariya AD. Dysregulated platelet function in COVID-19 patients. Akušerstvo, ginekologiâ i reprodukciâ 2023;16:692-705. [DOI: 10.17749/2313-7347/ob.gyn.rep.2022.372] [Reference Citation Analysis]
7 Petakh P, Kobyliak N, Kamyshnyi A. Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method. Front Cell Infect Microbiol 2023;13:1142578. [PMID: 36844398 DOI: 10.3389/fcimb.2023.1142578] [Reference Citation Analysis]
8 Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Youssef FS, El-Sherbeni SA, Negm WA. A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection. Inflammopharmacology 2023;31:9-19. [PMID: 36484974 DOI: 10.1007/s10787-022-01111-x] [Reference Citation Analysis]
9 Saritas Nakip O, Kesici S, Bozkurt BS, Ozsurekci Y, Demirbilek H, Bayrakci B. Incidence and Risk Factors of Hyperglycemia in Severe Multisystem Inflammatory Syndrome in Children: A Retrospective Case-Control Study. J Pediatr Infect Dis 2022. [DOI: 10.1055/s-0042-1758744] [Reference Citation Analysis]
10 Wakabayashi Y, Nakayama S, Yamamoto A, Kitazawa T. High D-glucose levels induce ACE2 expression via GLUT1 in human airway epithelial cell line Calu-3. BMC Mol and Cell Biol 2022;23:29. [DOI: 10.1186/s12860-022-00427-4] [Reference Citation Analysis]
11 Santos AACD, Rodrigues LE, Alecrim-zeza AL, de Araújo Ferreira L, Trettel CDS, Gimenes GM, Silva AFD, Sousa-filho CPB, Serdan TDA, Levada-pires AC, Hatanaka E, Borges FT, de Barros MP, Cury-boaventura MF, Bertolini GL, Cassolla P, Marzuca-nassr GN, Vitzel KF, Pithon-curi TC, Masi LN, Curi R, Gorjao R, Hirabara SM. Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1037467] [Reference Citation Analysis]
12 Al-Kuraishy HM, Al-Gareeb AI, Albogami SM, Jean-Marc S, Nadwa EH, Hafiz AA, A Negm W, Kamal M, Al-Jouboury M, Elekhnawy E, Batiha GE, Waard M. Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19. Pharmaceuticals (Basel) 2022;15. [PMID: 36355535 DOI: 10.3390/ph15111361] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Al-Kuraishy HM, Al-Gareeb AI, Albezrah NKA, Bahaa HA, El-Bouseary MM, Alexiou A, Al-Ziyadi SH, Batiha GE. Pregnancy and COVID-19: high or low risk of vertical transmission. Clin Exp Med 2022. [PMID: 36251144 DOI: 10.1007/s10238-022-00907-z] [Reference Citation Analysis]
14 Lu Y, Xing C, Lv X, Zhang C, Liu G, Chen F, Hou Z, Zhang D. Changes of ACE2 in different glucose metabolites and its relationship with COVID-19. Medicine (Baltimore) 2022;101:e31102. [PMID: 36253996 DOI: 10.1097/MD.0000000000031102] [Reference Citation Analysis]
15 Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Batiha GE. Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysauto-nomia. Curr Drug Targets 2022;23:1277-87. [PMID: 35950254 DOI: 10.2174/1389450123666220810102406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Alomair BM, Al-Kuraishy HM, Al-Buhadily AK, Al-Gareeb AI, De Waard M, Elekhnawy E, Batiha GE. Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy? Inflammopharmacology 2022. [PMID: 36180664 DOI: 10.1007/s10787-022-01078-9] [Reference Citation Analysis]
17 Al-Kuraishy HM, Al-Gareeb AI, Eldahshan OA, Batiha GE. Oxytocin in diabetic Covid-19 patients: a new perspective. Nat Prod Res 2022;:1-2. [PMID: 36121763 DOI: 10.1080/14786419.2022.2124410] [Reference Citation Analysis]
18 Parthasarathy S, Chamorro-pareja N, Kharawala A, Hupart KH, Curcio J, Coyle C, Buchnea D, Karamanis D, Faillace R, Palaiodimos L, Kishore P. Diabetic Ketoacidosis Was Associated with High Morbidity and Mortality in Hospitalized Patients with COVID-19 in the NYC Public Health System. Diabetology 2022;3:477-493. [DOI: 10.3390/diabetology3030036] [Reference Citation Analysis]
19 Al-Kuraishy HM, Al-Buhadily AK, Al-Gareeb AI, Alorabi M, Hadi Al-Harcan NA, El-Bouseary MM, Batiha GE. Citicoline and COVID-19: vis-à-vis conjectured. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 36063198 DOI: 10.1007/s00210-022-02284-6] [Reference Citation Analysis]
20 Mortazavi-Jahromi SS, Aslani M. Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation. Int Immunopharmacol 2022;110:109040. [PMID: 35839566 DOI: 10.1016/j.intimp.2022.109040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Farakla I, Lagousi T, Miligkos M, Nicolaides N, Vasilakis I, Mpinou M, Dolianiti M, Katechaki E, Taliou A, Spoulou V, Kanaka-gantenbein C. Stress hyperglycemia, Diabetes mellitus and COVID-19 infection: The impact on newly diagnosed type 1 diabetes. Front Clin Diabetes Healthc 2022;3. [DOI: 10.3389/fcdhc.2022.818945] [Reference Citation Analysis]
22 Alkazmi L, Al-Kuraishy HM, Batiha GE, Mostafa-Hedeab G, De Waard M, Sabatier JM, Kabrah SM, Saad HM, Al-Gareeb AI, Simal-Gandara J. Roxadustat for SARS-CoV-2 Infection: Old Signaling Raised New Hopes. Drugs R D 2022. [PMID: 36006604 DOI: 10.1007/s40268-022-00397-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Matysek A, Studnicka A, Smith WM, Hutny M, Gajewski P, Filipiak KJ, Goh J, Yang G. Influence of Co-morbidities During SARS-CoV-2 Infection in an Indian Population. Front Med 2022;9. [DOI: 10.3389/fmed.2022.962101] [Reference Citation Analysis]
24 Al-Kuraishy HM, Al-Gareeb AI, Al-Niemi MS, Aljowaie RM, Almutairi SM, Alexiou A, Batiha GE. The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19. Inflammation 2022;45:1651-67. [PMID: 35199285 DOI: 10.1007/s10753-022-01648-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
25 Liptak P, Baranovicova E, Rosolanka R, Simekova K, Bobcakova A, Vysehradsky R, Duricek M, Dankova Z, Kapinova A, Dvorska D, Halasova E, Banovcin P. Persistence of Metabolomic Changes in Patients during Post-COVID Phase: A Prospective, Observational Study. Metabolites 2022;12:641. [DOI: 10.3390/metabo12070641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Al-kuraishy HM, Al-gareeb AI, Al-hamash SM, Cavalu S, El-bouseary MM, Sonbol FI, Batiha GE. Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection. Front Med 2022;9:876017. [DOI: 10.3389/fmed.2022.876017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Al-Kuraishy HM, Al-Gareeb AI, Kaushik A, Kujawska M, Batiha GE. Ginkgo biloba in the management of the COVID-19 severity. Arch Pharm (Weinheim) 2022;:e2200188. [PMID: 35672257 DOI: 10.1002/ardp.202200188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Lotfy MA, Shama AA. Intensive insulin therapy improves the survival probability of non-diabetic COVID-19 patients presenting with acute hyperglycemia. Egyptian Journal of Anaesthesia 2022;38:211-9. [DOI: 10.1080/11101849.2022.2060636] [Reference Citation Analysis]
29 Pan P, Du X, Zhou Q, Cui Y, Deng X, Liu C, Hu Z, Chen J, Yu X, Shi W. Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19. Virol J 2022;19:57. [PMID: 35346253 DOI: 10.1186/s12985-022-01786-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Gökmen İB, Yiğit SE, Okuturlar Y, Köksal İ. COVID-19 Presenting with Diabetic Ketoacidosis: A case report. Turkish Journal of Internal Medicine. [DOI: 10.46310/tjim.1073576] [Reference Citation Analysis]
31 Soto ME, Guarner-Lans V, Díaz-Díaz E, Manzano-Pech L, Palacios-Chavarría A, Valdez-Vázquez RR, Aisa-Álvarez A, Saucedo-Orozco H, Pérez-Torres I. Hyperglycemia and Loss of Redox Homeostasis in COVID-19 Patients. Cells 2022;11. [PMID: 35326383 DOI: 10.3390/cells11060932] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
32 Souza Pereira MA, Rezende‐silva E, Barbosa BF, Albuquerque HIM, Almeida Souza LM, Mota Santana LA. Neurological, haemodynamic and metabolic disturbs are prevalent symptoms in oral surgeons with post‐COVID ‐19. Oral Surgery 2022. [DOI: 10.1111/ors.12734] [Reference Citation Analysis]
33 Henein MY, Cameli M, Pastore MC, Mandoli GE. COVID-19 Severity and Cardiovascular Disease: An Inseparable Link. JCM 2022;11:479. [DOI: 10.3390/jcm11030479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. Int Immunopharmacol 2022;104:108516. [PMID: 35032828 DOI: 10.1016/j.intimp.2021.108516] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 30.0] [Reference Citation Analysis]
35 Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G, Kasozi KI, Zirintunda G, Aslam A, Allahyani M, Welburn SC, Batiha GE. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19. Front Immunol 2021;12:749291. [PMID: 34867978 DOI: 10.3389/fimmu.2021.749291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
36 Zhang MM, Chen LN, Qian JM. Gastrointestinal manifestations and possible mechanisms of COVID-19 in different periods. J Dig Dis 2021;22:683-94. [PMID: 34738727 DOI: 10.1111/1751-2980.13065] [Reference Citation Analysis]
37 Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Alexiou A, Batiha GE. Niclosamide for Covid-19: bridging the gap. Mol Biol Rep 2021;48:8195-202. [PMID: 34664162 DOI: 10.1007/s11033-021-06770-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
38 Kharechkina ES, Nikiforova AB, Belosludtsev KN, Rokitskaya TI, Antonenko YN, Kruglov AG. Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition. Pharmaceuticals (Basel) 2021;14:1045. [PMID: 34681269 DOI: 10.3390/ph14101045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Patil P, Shetty P, Kuriakose N, Gollapalli P, Shetty S, Bhandary R, Vishwanatha JK, Ghate SD. Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications. Int J Mol Sci 2021;22:11028. [PMID: 34681689 DOI: 10.3390/ijms222011028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Chaturvedi S, Gupta P. Evaluation of Bioactive Metabolites and Antioxidant-Rich Extracts of Amaranths with Possible Role in Pancreatic Lipase Interaction: In Silico and In Vitro Studies. Metabolites 2021;11:676. [PMID: 34677391 DOI: 10.3390/metabo11100676] [Reference Citation Analysis]
41 Onohuean H, Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Batiha GE. Covid-19 and development of heart failure: mystery and truth. Naunyn Schmiedebergs Arch Pharmacol 2021;394:2013-21. [PMID: 34480616 DOI: 10.1007/s00210-021-02147-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
42 Magdy Beshbishy A, Oti VB, Hussein DE, Rehan IF, Adeyemi OS, Rivero-Perez N, Zaragoza-Bastida A, Shah MA, Abouelezz K, Hetta HF, Cruz-Martins N, Batiha GE. Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review. Front Public Health 2021;9:591982. [PMID: 34307267 DOI: 10.3389/fpubh.2021.591982] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
43 Al-Kuraishy HM, Al-Gareeb AI, Atanu FO, El-Zamkan MA, Diab HM, Ahmed AS, Al-Maiahy TJ, Obaidullah AJ, Alshehri S, Ghoniem MM, Batiha GE. Maternal Transmission of SARS-CoV-2: Safety of Breastfeeding in Infants Born to Infected Mothers. Front Pediatr 2021;9:738263. [PMID: 34956971 DOI: 10.3389/fped.2021.738263] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
44 Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Cruz-Martins N, Batiha GE. The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem 2021;476:4161-6. [PMID: 34319496 DOI: 10.1007/s11010-021-04232-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 16.5] [Reference Citation Analysis]